Serial analysis of the effects of methimazole or radical therapy on circulating CD16/56 subpopulations in Graves' disease

European Journal of Endocrinology

Volumn 139, Issue 3, 1998, Pages 314-316

  Rojano, J ^a   Sasian S ^a   Gavilan I ^a   Aguilar, M ^a   Escobar, L ^a   Giron J A ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; THIAMAZOLE; THYROXINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOFLUOROMETRY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROGNOSIS; THYROID FUNCTION TEST;

ADULT; ANTIGENS, CD56; ANTITHYROID AGENTS; AUTOANTIBODIES; BIOLOGICAL MARKERS; FEMALE; GRAVES DISEASE; HUMANS; KILLER CELLS, NATURAL; MALE; METHIMAZOLE; RECEPTORS, IGG; T-LYMPHOCYTES, CYTOTOXIC; THYROID HORMONES; THYROIDITIS, AUTOIMMUNE;

EID: 0031657617     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1390314     Document Type: Article

References (17)

1. Bottazzo GF & Doniach D. Autoimmune thyroid disease. Annual Review of Medicine 1986 37 353-359.
2. Marazuela M, Postigo AA, Acevedo A, Díaz-González F, Sánchez-Madrid F & O de Landazuri E. Adhesion molecules from the LFA-1/ICAM-1,3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands. European Journal of Immunology 1994 24 2483-2490.
3. Mariotti S, del Prette GF, Mastromauro C, de Carli M, Romagnani S, Ricci M & Pinchera A. The autoimmune infiltrate of Basedow's disease: analysis of clonal level and comparison with Hashimoto's thyroiditis. Experimental and Clinical Endocrinology 1991 97 139-146.
4. Karlsson FA & Totterman TH. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets. B cells and NK cells. Clinical and Experimental Immunology 1988 74 258-263.
5. Ohashi H, Okugawa T & Itoh M. Circulating activated T cell subsets in autoimmune thyroid diseases: differences between untreated and treated patients. Acta Endocrinologica 1991 125 502-509.
6. Teng WP, Cohen SB, Posnett DN & Weetman AP. T cell receptor phenotypes in autoimmune thyroid disease. Journal of Endocrinological Investigation 1990 13 339-342.
7. Iwatani Y, Amino N, Hidaka Y, Kaneda T, Ichihara K, Tamaka H et al. Decreases in alpha beta T cell receptor, negative T cells and CD8 cells and an increase in CD4+CD8+ cells in active Hashimoto's disease and subacute thyroiditis. Clinical and Experimental Immunology 1992 87 444-449.
8. Roura IC, Alcalde L, Vargas F, Tolosa E, Obiols G, Foz M et al. Gamma delta lymphocytes in endocrine autoimmunity in Graves' disease but not in type 1 diabetes. Clinical and Experimental Immunology 1993 92 288-295.
9. Iwatani Y, Amino N, Kaneda T, Ichihara K, Tamaki H, Tachi J et al. Marked increase of CD5+ B cells in hyperthyroid Graves' disease. Clinical and Experimental Immunology 1989 78 196-200.
10. Corrales JJ, Orfao A, López A, Ciudad J & Mories MT. Serial analysis of the effects of methimazole therapy on circulating B cell subsets in Graves' disease. Journal of Endocrinology 1996 151 231-240.
11. Papic M, Stein-Streilein J Zakarija M, McKenzie JM, Guffee J & Fletcher MA. Suppression of peripheral blood natural killer cell activity by excess thyroid hormone. Journal of Clinical Investigation 1987 79 404-408.
12. Tezuka H, Eguchi K, Fukuda T, Otsubo T, Kawabe Y, Ueki Y et al. Natural killer and natural killer-like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease. Journal of Clinical Endocrinology and Metabolism 1988 66 702-707.
13. Wall JR, Baur R, Schleusener H & Bandy-Dafoe P. Peripheral blood and intrathyroidal mononuclear cell populations in patients with autoimmune thyroid disorders enumerated using monoclonal antibodies. Journal of Clinical Endocrinology and Metabolism 1983 56 164-169.
14. Larsen PR & Ingbar SH. The thyroid gland. In Williams Textbook of Endocrinology, pp 356-487. Eds JD Wilson & DW Foster. Philadelphia: WB Saunders, 1992.
15. Laso FJ, Madruga JI, Girón JA, López A, Ciudad J, San Miguel JF et al. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption. Hepatology 1997 25 1096-1110.
16. Weetman AP & McGregor AM. Autoimmune thyroid disease: developments in our understanding. Endocrine Review 1994 15 309-355.
17. Lanier L, Le LAM, Civin CI, Loken MR & Phillips JH. The relationship of CD16 (Leu 11) and Leu 19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. Journal of Immunology 1986 136 4480-4486.